What is Anupam Rasayan India Ltd's market cap?

Anupam Rasayan India Ltd (ANURAS) has a market capitalization of ₹15,472 Cr.

What sector is ANURAS in?

Anupam Rasayan India Ltd operates in the Chemicals — Specialty & Commodity sector.

What is ANURAS's return on equity?

Anupam Rasayan India Ltd has a return on equity (ROE) of 5.4%.

Loading company...

Analyzing...

Anupam Rasayan India Ltd (ANURAS) — Analysis, Financials, Intelligence | The Stock Filter

The Organism · Company Intelligence

Anupam Rasayan India Ltd

ANURAS|BSE: 543275

Chemicals — Specialty & CommodityChemicals & Materialswww.anupamrasayan.com

—

—|MCap ₹15,472 Cr

Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-03-24. The Company’s segments includ

Secular Currents

Theme Connections

PLI Manufacturing EV Transition Green Hydrogen Rural Consumption Healthcare Access

Intelligence Profile

TSF Score

57/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

17Clean

Trust Score

X-Ray

Concerns

🟠Below-average return on equity (5.4%)Business
🟠Profit decliningBusiness

Watch

Nothing flagged for monitoring

Strengths

🟢Healthy revenue growth (10.2% CAGR 3yr)Business
🟢Low leverage (D/E: 0.37x)Business
🟢Consistent dividend payerOpportunity

The Numbers · Key Metrics

ROE

5.4%

Revenue Growth 3yr

10.2%

Debt/Equity

0.37x

₹15,359 Cr

The Narrator · StoryTel Intelligence

FY2025Chemicals — Specialty & CommodityProduct Sales ModelModel:Revenue = Production Volume × Average Selling Price

Key Insight

“Operates in Chemicals — Specialty & Commodity.”

The Revenue Story

₹1,437 Cr revenue.

Total Income₹1,448 Cr

Revenue₹1,437 Cr(99.2% of Total Income)

Other Income₹11 Cr(0.8% of Total Income)

The Cost Story

COGS 42.1%, employees 5.1%.

Cogs₹604 Cr(36.4%)

EBITDA₹412 Cr(24.8%)

Other Expenses₹358 Cr(21.5%)

Finance Costs₹112 Cr(6.7%)

Depreciation₹102 Cr(6.2%)

Employee₹74 Cr(4.4%)

0.2%EBITDA Margin

Cogs

36.4%

EBITDA

24.8%

Other Expenses

21.5%

Finance Costs

6.7%

Depreciation

6.2%

Employee

4.4%

Key Metrics

ROE

5.4%

vs median 7.6%

ROCE

11.4%

vs median 10.9%

Net Margin

7.6%

vs median 5.1%

EBITDA Margin

24.6%

vs median 12.1%

Debt To Equity

0.37x

vs median 0.20x

Rev Growth 3yr

10.2%

vs median 5.9%

EPS Growth 3yr

-17.6%

vs median -9.4%

Forward View · Management Guidance

FINANCIALQ2FY26— 8High Impact

“gross block has increased from 14,000,000,000 in FY '22 to almost 24,000,000,000 in FY 2025 whereas your EBITDA is declined from 300 crores to $2.65 crores”

FINANCIALQ2FY26— 5High Impact

“operating cash flow of over $3.50 crores...on a standard basis also...it would have been over 300 crores”

FINANCIALQ2FY26— 4High Impact

“Working capital days decreased from 409 days to 247 days. Target to reduce to 200 days in near term. Net debt reduced to INR 7.30 crores.”

The Context · Where does it sit?

Sector Context

The Canopy · Sector KPIs

Sector KPIs

Chemicals — Specialty & Commodity

KPI	Company	Sector Median
ROE	5.4%▼	7.6%
ROCE	11.4%▲	10.9%
Net Margin	7.6%▲	5.1%
EBITDA Margin	24.6%▲	12.1%
Debt To Equity	0.37x▲	0.20x
Rev Growth 3yr	10.2%▲	5.9%
EPS Growth 3yr	-17.6%▼	-9.4%

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Low Impact

7d+0.50→30d+0.50

Based on 2 articles (0 in last 7 days)

The Numbers · Show me the data

Financials

No valuation data

Historical valuation data not available.

Financials

Revenue₹2,230 Cr

PBT₹286 Cr

EPS₹15.36

(₹ Cr)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	₹2,230 Cr +55.2%	₹1,437 Cr -2.6%	₹1,475 Cr -7.9%	₹1,602 Cr +50.3%	₹1,066 Cr +31.5%	₹811 Cr
Other Income	₹20 Cr +77.3%	₹11 Cr -62.1%	₹30 Cr +253.0%	₹9 Cr -43.3%	₹15 Cr -42.9%	₹26 Cr
Total Income	₹2,250 Cr +55.4%	₹1,448 Cr -3.8%	₹1,505 Cr -6.5%	₹1,610 Cr +49.0%	₹1,081 Cr +29.1%	₹837 Cr
COGS	₹1,229 Cr +103.4%	₹604 Cr -1.6%	₹614 Cr -12.7%	₹704 Cr +90.2%	₹370 Cr +9.1%	₹339 Cr
	₹1,964 Cr +57.0%	₹1,251 Cr -1.0%	₹1,264 Cr -3.1%	₹1,304 Cr +51.7%	₹860 Cr +16.6%	₹737 Cr
Profit Before Tax	₹286 Cr +44.8%	₹198 Cr -18.2%	₹242 Cr -21.0%	₹306 Cr +38.4%	₹221 Cr +121.2%	₹100 Cr
	₹57 Cr +51.3%	₹38 Cr -49.0%	₹74 Cr -18.1%	₹91 Cr +30.3%	₹70 Cr +134.5%	₹30 Cr
Net Profit	₹229 Cr +43.2%	₹160 Cr -4.5%	₹167 Cr -22.8%	₹217 Cr +42.5%	₹152 Cr +116.5%	₹70 Cr
Profit (Owners)	₹172 Cr +84.3%	₹93 Cr -27.4%	₹129 Cr -28.9%	₹181 Cr +18.8%	₹152 Cr +116.5%	₹70 Cr
Minority Interest	₹57 Cr -14.3%	₹67 Cr +71.6%	₹39 Cr +7.9%	₹36 Cr	₹0.00 Cr	₹0.00 Cr
Other Comprehensive Income	(₹0.88 Cr) ↓ Decline	₹1 Cr ↑ Recovery	(₹0.68 Cr) +59.5%	(₹2 Cr) -101.6%	(₹0.84 Cr) -12.0%	(₹0.75 Cr)
EPS	₹15.36	₹8.49	₹11.71	₹16.83	₹15.18	₹7.04
Diluted Shares	₹11 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹10 Cr	₹10 Cr